Journals / Journal of the Turkish-German Gynecological Association / 2012 / Cilt: 13 - Sayı: 1

Myoma uteri içerisinde ekstramedullar hematopoiezis

Extramedullary hematopoiesis in leiomyoma uteri

Pages
61–63
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is currently no consensus regarding the pathogenesis and clinical management of this uncommon pathology and further reports on this topic are needed. (J Turkish-German Gynecol Assoc 2012; 13: 61-3)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Extramedullary hematopoiesis (EMH) that often occurs as a compensatory reaction to an underlying hematologic abnormality is a non-neoplastic proliferation of hematopoietic tissue outside the bone marrow and peripheral blood.
📊
Key Findings & Data:EMH is most commonly (95%) seen in reticuloendothelial organs such as the spleen, liver, and lymph nodes but has rarely been reported in other locations.
💡
Conclusion & Impact:There is currently no consensus regarding the pathogenesis and clinical management of this uncommon pathology and further reports on this topic are needed. (J Turkish-German Gynecol Assoc 2012; 13: 61-3)
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Extramedullary hematopoiesis (EMH) that often occurs as a compensatory reaction to an underlying hematologic abnormality is a non-neoplastic proliferation of hematopoietic tissue outside the bone marrow and peripheral blood. Rarely, EMH may be seen in hematologically normal individuals. EMH is most commonly (95%) seen in reticuloendothelial organs such as the spleen, liver, and lymph nodes but has rarely been reported in other locations. EMH is extremely rare in the uterus. In this case report, we present EMH in leiomyoma uteri in patients without any underlying hematologic abnormalities. Very rare clinical conditions like EMH can be observed in cases of myoma uteri and therefore should be kept in mind. There is currently no consensus regarding the pathogenesis and clinical management of this uncommon pathology and further reports on this topic are needed. (J Turkish-German Gynecol Assoc 2012; 13: 61-3)

Özet

Kemik iliği ve periferik kan dışında hematopoietik dokuların neoplastik olmayan proliferasyonu olarak tanımlanan ekstramedullar hematopoiezis (EMH) nadir olarak sağlıklı kişlerde görülür. Yine EMH çok nadir olarak uterusta görülebilir. Bu sunumda hematolojik olarak normal izlenen bir olguda myoma uteri içerisinde saptanan EMH durumu tartışılmıştır. Dejenere 8x10 cm büyüklüğünde intramural-subseröz myoma uteri saptanan 43 yaşındaki hastaya histerektomi operasyonu uygulanmıştır. Patoloji örneğinin histolojik incelemesi sonucunda mitotik aktif leiomyoma uteri ile birlikte EMH saptanmıştır. Takiben yapılan sistemik araştırmada, periferik yayma ve kemik iliği biopsisini de içeren detaylı laboratuvar bulguları normal olarak izlenmiştir. EMH gibi nadir klinik durumlar myoma uteri içerisinde izlenebilir. Günümüzde bu nadir durumun patogenezi ve klinik yaklaşımı konusunda fikir birliği yoktur. Bu konuda yeni yayınlara ihtiyaç vardır. (J Turkish-German Gynecol Assoc 2012; 13: 61-3)

🔖

Cite This Article

PEHLİVAN, M., AYDIN, A., BALAT, Ö., ÖZTÜRK, E., UĞUR, M. G. (2022). Myoma uteri içerisinde ekstramedullar hematopoiezis. Journal of the Turkish-German Gynecological Association, Cilt: 13 - Sayı: 1, 61–63. https://ajindex.com/articles/567691

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Al-Aabassi A, Murad BA. Presacral extramedullary hematopoiesis: a diagnostic confusion concerning a rare presentation. Med Princ Pract 2005; 14: 358-62. [CrossRef] 2. Gupta P, Eshaghi N, Ghole V, Ketkar M, Garcia-Morales F. Presacral extramedullary hematopoiesis: report of a case and review of the literature. Clin Imaging 2008; 32: 487-9. [CrossRef] 3. Koch CA, Li CY, Mesa RA, Tefferi A. Nonhepatosplenic extramedullary hematopoiesis: associated diseases, pathology, clinical course, and treatment. Mayo Clin Proc 2003; 78: 1223-33. [CrossRef] 4. Sirgi KE, Swanson PE, Gersell DJ. Extramedullary hematopoiesis in the endometrium. Report of four cases and review of the literature. Am J Clin Pathol 1994; 101: 643-6. 5. Pandey U, Aluwihare N, Light A, Hamilton M. Extramedullary haemopoiesis in the cervix. Histopathology 1999; 34: 556-7. [CrossRef] 6. Valeri RM, Ibrahim N, Sheaff MT. Extramedullary hematopoiesis in the endometrium. Int J Gynecol Pathol 2002; 21: 178-81. [CrossRef] 7. Schmid C, Beham A, Kratochvil P. Haematopoiesis in a degenerating uterine leiomyoma. Arch Gynecol Obstet 1990; 248: 81-6. [CrossRef] 8. Ward HP, Block MH. The natural history of anogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 1971; 50; 357-420. [CrossRef] 9. Rencricca NJ, Rizzoli V, Howard D, Duffy P, Stohlman F Jr. Stem cell migration and proliferation during severe anemia. Blood 1970; 36; 764-71. 10. Sun Z, Zhang Y, Brunt KR, Wu J, Li SH, Fazel S, et al. An adult uterine hemangioblast: evidence for extramedullary self-renewal and clonal bilineage potential. Blood 2010; 116: 2932-41. [CrossRef] 11. Zhou S, Yi T, Shen K, Zhang B, Huang F, Zhao X. Hypoxia: The driving force of uterine myometrial stem cells differentiation into leiomyoma cells. Med Hypotheses 2011; 77: 985-6. [CrossRef]